“Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective” (2022) Biomolecules and Biomedicine, 22(5), pp. 699–706. doi:10.17305/bjbms.2021.7326.